Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'RIMANTADINE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 97 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Suckow, RF
      Separation methods for tricyclic antiviral drugs

      JOURNAL OF CHROMATOGRAPHY B
    2. Teuber, G; Berg, T; Naumann, U; Raedle, J; Brinkmann, S; Hopf, U; Zeuzem, S
      Randomized, placebo-controlled, double-blind trial with interferon-alpha with and without amantadine sulphate in primary interferon-alpha nonresponders with chronic hepatitis C

      JOURNAL OF VIRAL HEPATITIS
    3. Chladek, J; Sispera, L; Martinkova, J; Zaludek, B; Sova, P; Mieuda, S; Grim, J; Cermanova, J; Zaludek, B; Sova, P; Franc, A
      Bioequivalence of two rimantadine tablet formulations in healthy male volunteers after single dose administration

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    4. Whitley, RJ; Hayden, FG; Reisinger, KS; Young, N; Dutkowski, R; Ipe, D; Mills, RG; Ward, P
      Oral oseltamivir treatment of influenza in children

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    5. Gaillat, J
      An assessment of the antiviral treatment against the flu in 2001

      REVUE DE MEDECINE INTERNE
    6. Craxi, A; Lo Iacono, O
      Amantadine for chronic hepatitis C: a magic bullet or yet another dead duck?

      JOURNAL OF HEPATOLOGY
    7. Zambon, M; Hayden, FG
      Position statement: global neuraminidase inhibitor susceptibility network

      ANTIVIRAL RESEARCH
    8. Dreitlein, WB; Maratos, J; Brocavich, J
      Zanamivir and oseltamivir: Two new options for the treatment and prevention of influenza

      CLINICAL THERAPEUTICS
    9. Welliver, R; Monto, AS; Carewicz, O; Schatteman, E; Hassman, M; Hedrick, J; Jackson, HC; Huson, L; Ward, P; Oxford, JS
      Effectiveness of oseltamivir in preventing influenza in household contacts- A randomized controlled trial

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    10. Iwahashi, J; Tsuji, K; Ishibashi, T; Kajiwara, J; Imamura, Y; Mori, R; Hara, K; Kashiwagi, T; Ohtsu, Y; Hamada, N; Maeda, H; Toyoda, R; Toyoda, T
      Isolation of amantadine-resistant influenza A viruses (H3N2) from patientsfollowing administration of amantadine in Japan

      JOURNAL OF CLINICAL MICROBIOLOGY
    11. Kelly, JM; Quack, G; Miles, MM
      In vitro and in vivo activities of aminoadamantane and aminoalkylcyclohexane derivatives against Trypanosoma brucei

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    12. Berg, T; Naumann, U; Wiedenmann, B; Hopf, U
      Pilot study of interferon-alpha high-dose induction therapy in combinationwith ribavirin plus amantadine for nonresponder patients with chronic hepatitis C

      ZEITSCHRIFT FUR GASTROENTEROLOGIE
    13. McClellan, K; Perry, CM
      Oseltamivir - A review of its use in influenza

      DRUGS
    14. Nassar, AEF; Varshney, N; Getek, T
      Rapid high-performance liquid chromatography/tandem mass spectrometry APCImethod for determination of nitrogen containing compounds in plasma

      ANALYTICAL LETTERS
    15. Peters, PH; Gravenstein, S; Norwood, P; De Bock, V; Van Couter, A; Gibbens, M; von Planta, TA; Ward, P
      Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population

      JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
    16. Snacken, R
      Managing influenza in primary care - A practical guide to clinical diagnosis

      DISEASE MANAGEMENT & HEALTH OUTCOMES
    17. Jackson, HC; Roberts, N; Wang, ZM; Belshe, R
      Management of influenza - Use of new antivirals and resistance in perspective

      CLINICAL DRUG INVESTIGATION
    18. Murphy, KR; Eivindson, A; Pauksens, K; Stein, WJ; Tellier, G; Watts, R; Leophonte, P; Sharp, SJ; Loeschel, E
      Efficacy and safety of inhaled zanamivir for the treatment of influenza inpatients with asthma or chronic obstructive pulmonary disease - A double-blind, randomised, placebo-controlled, multicentre study

      CLINICAL DRUG INVESTIGATION
    19. Liu, J; Mei, WJ; Li, YG; Wang, E; Ji, LN; Tao, PZ
      Antiviral activity of mixed-valence rare earth borotungstate heteropoly blues against influenza virus in mice

      ANTIVIRAL CHEMISTRY & CHEMOTHERAPY
    20. Andant, C; Lamoril, J; Deybach, JC; Jouet, P; Soule, JC
      Amantadine for chronic hepatitis C: pilot study in 14 patients

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    21. Mileva, M; Hadjimitova, V; Tantcheva, L; Traykov, T; Galabov, AS; Savov, V; Ribarov, S
      Antioxidant properties of rimantadine in influenza virus infected mice andin some model systems

      ZEITSCHRIFT FUR NATURFORSCHUNG C-A JOURNAL OF BIOSCIENCES
    22. Lee, C; Loeb, M; Phillips, A; Nesbitt, J; Smith, K; Fearon, M; McArthur, MA; Mazzulli, T; Li, Y; McGeer, A
      Zanamivir use during transmission of amantadine-resistant influenza A in anursing home

      INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
    23. Drinka, PJ; Gravenstein, S; Krause, P; Nest, L; Dissing, M; Shult, P
      Reintroduction of influenza A to a nursing building

      INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
    24. Hedrick, JA; Barzilai, A; Behre, U; Henderson, FW; Hammond, J; Reilly, L; Keene, O
      Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    25. Masuda, H; Suzuki, H; Oshitani, H; Saito, R; Kawasaki, S; Nishikawa, M; Satoh, H
      Incidence of amantadine-resistant influenza A viruses in sentinel surveillance sites and nursing homes in Niigata, Japan

      MICROBIOLOGY AND IMMUNOLOGY
    26. Serkedjieva, J; Danova, S; Ivanova, I
      Antiinfluenza virus activity of a bacteriocin produced by Lactobacillus delbrueckii

      APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
    27. Zeuzem, S; Teuber, G; Naumann, U; Berg, T; Raedle, J; Hartmann, S; Hopf, U
      Randomized, double-blind, placebo-controlled trial of interferon Alfa2a with and without amantadine as initial treatment for chronic hepatitis C

      HEPATOLOGY
    28. Hayden, FG
      Influenza virus and rhinovirus-related otitis media: potential for antiviral intervention

      VACCINE
    29. Leneva, IA; Roberts, N; Govorkova, EA; Goloubeva, OG; Webster, RG
      The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses

      ANTIVIRAL RESEARCH
    30. Makela, MJ; Pauksens, K; Rostila, T; Fleming, DM; Man, CY; Keene, ON; Webster, A
      Clinical efficacy and safety of the orally inhaled neuraminidase inhibitorzanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study

      JOURNAL OF INFECTION
    31. Dawson, J
      Neuraminidase inhibitor and amantadine

      LANCET
    32. Treanor, JJ; Hayden, FG; Vrooman, PS; Barbarash, R; Bettis, R; Riff, D; Singh, S; Kinnersley, N; Ward, P; Mills, RG
      Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza - A randomized controlled trial

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    33. Caserta, MT; Hall, CB
      Antiviral agents for influenza

      PEDIATRIC ANNALS
    34. Hayden, FG; Gubareva, LV; Monto, AS; Klein, TC; Elliott, MJ; Hammond, JM; Sharp, SJ; Ossi, MJ
      Inhaled zanamivir for the prevention of influenza in families.

      NEW ENGLAND JOURNAL OF MEDICINE
    35. Monto, AS; Gravenstein, S; Elliott, M; Colopy, M; Schweinle, J
      Clinical signs and symptoms predicting influenza infection

      ARCHIVES OF INTERNAL MEDICINE
    36. Zadeh, MM; Bridges, CB; Thompson, WW; Arden, NH; Fukuda, K
      Influenza outbreak detection and control measures in nursing homes in the United States

      JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
    37. Suckow, RF; Zhang, MF; Collins, ED; Fischman, MW; Cooper, TB
      Sensitive and selective liquid chromatographic assay of memantine in plasma with fluorescence detection after pre-column derivatization

      JOURNAL OF CHROMATOGRAPHY B
    38. Couch, RB
      Measures for control of influenza

      PHARMACOECONOMICS
    39. Munoz, FM; Campbell, JR; Atmar, RL; Garcia-Prats, J; Baxter, BD; Johnson, LE; Englund, JA
      Influenza A virus outbreak in a neonatal intensive care unit

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    40. Silagy, CA; Campion, K
      Effectiveness and role of zanamivir in the treatment of influenza infection

      ANNALS OF MEDICINE
    41. Evidente, VGH; Adler, CH; Caviness, JN; Gwinn-Hardy, K
      A pilot study on the motor effects of rimantadine in Parkinson's disease

      CLINICAL NEUROPHARMACOLOGY
    42. He, G; Massarella, J; Ward, P
      Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802

      CLINICAL PHARMACOKINETICS
    43. Webster, A; Boyce, M; Edmundson, S; Miller, I
      Coadministration of orally inhaled zanamivir with inactivated trivalent influenza vaccine does not adversely affect the production of antihaemagglutinin antibodies in the serum of healthy volunteers

      CLINICAL PHARMACOKINETICS
    44. Stephenson, I; Nicholson, KG
      Chemotherapeutic control of influenza

      Journal of antimicrobial chemotherapy
    45. Colman, PM
      A novel approach to antiviral therapy for influenza

      Journal of antimicrobial chemotherapy
    46. Monto, AS; Webster, A; Keene, O
      Randomized, placebo-controlled studies of inhaled zanamivir in the treatment of influenza A and B: pooled efficacy analysis

      Journal of antimicrobial chemotherapy
    47. Younossi, ZM; Perrillo, RP
      The roles of amantadine, rimantadine, ursodeoxycholic acid, and NSAIDs, alone or in combination with alpha interferons, in the treatment of chronic hepatitis C

      SEMINARS IN LIVER DISEASE
    48. Freund, B; Gravenstein, S; Elliott, M; Miller, I
      Zanamivir - A review of clinical safety

      DRUG SAFETY
    49. Monto, AS; Robinson, DP; Herlocher, ML; Hinson, JM; Elliott, MJ; Crisp, A
      Zanamivir in the prevention of influenza among healthy adults - a randomized controlled trial

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    50. Fenton, RJ; Morley, PJ; Owens, IJ; Gower, D; Parry, S; Crossman, L; Wong, T
      Chemoprophylaxis of influenza A virus infections, with single doses of zanamivir, demonstrates that zanamivir is cleared slowly from the respiratory tract

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    51. Hayden, FG; Atmar, RL; Schilling, M; Johnson, C; Poretz, D; Paar, D; Huson, L; Ward, P; Mills, RG
      Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza

      NEW ENGLAND JOURNAL OF MEDICINE
    52. Monto, AS; Fleming, DM; Henry, D; de Groot, R; Makela, H; Klein, T; Elliott, M; Keene, ON; Man, CY
      Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza A and B virus infections

      JOURNAL OF INFECTIOUS DISEASES
    53. OXFORD JS; LAMBKIN R
      TARGETING INFLUENZA-VIRUS NEURAMINIDASE - A NEW STRATEGY FOR ANTIVIRAL THERAPY

      Drug discovery today
    54. SCHOLTISSEK C; WEBSTER RG
      LONG-TERM STABILITY OF THE ANTIINFLUENZA-A COMPOUNDS - AMANTADINE ANDRIMANTADINE

      Antiviral research
    55. Silagy, C; Campion, K; Keene, O; Cooper, C; Bolton, P; Watts, R; Liaw, T; Narayan, K; Delooze, F; Narayan, K; Dunne, J; Stewart, R; Gilzan, C; Cooper, C; Bolton, P; Mira, M; Lavis, S; Batey, C; Liaw, T; Scarfo, M; Silagy, C; Wesslinghe, S; Girke, T; Roberts, P; Watts, R; Stanley, J; Cook, N; Delooze, F; McKeirnan, M; Hartl, G; Peterson, V; Becker, M; Drewry, A; Ratima, K; Sauer, F; Clark, M; Wright, L
      Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections

      LANCET
    56. LI WX; ESCARPE PA; EISENBERG EJ; CUNDY KC; SWEET C; JAKEMAN KJ; MERSON J; LEW W; WILLIAMS M; ZHANG LJ; KIM CU; BISCHOFBERGER N; CHEN MS; MENDEL DB
      IDENTIFICATION OF GS-4104 AS AN ORALLY BIOAVAILABLE PRODRUG OF THE INFLUENZA-VIRUS NEURAMINIDASE INHIBITOR GS-4071

      Antimicrobial agents and chemotherapy
    57. STILIANAKIS NI; PERELSON AS; HAYDEN FG
      EMERGENCE OF DRUG-RESISTANCE DURING AN INFLUENZA EPIDEMIC - INSIGHTS FROM A MATHEMATICAL-MODEL

      The Journal of infectious diseases
    58. REVILLA AL; HAMACEK J; HAVEL J
      DETERMINATION OF RIMANTADINE IN PHARMACEUTICAL PREPARATIONS BY CAPILLARY-ZONE-ELECTROPHORESIS WITH INDIRECT DETECTION OR AFTER DERIVATIZATION

      Chromatographia
    59. DRINKA PJ; GRAVENSTEIN S; SCHILLING M; KRAUSE P; MILLER BA; SHULT P
      DURATION OF ANTIVIRAL PROPHYLAXIS DURING NURSING-HOME OUTBREAKS OF INFLUENZA-A - A COMPARISON OF 2 PROTOCOLS

      Archives of internal medicine
    60. YOUSUF HM; ENGLUND J; COUCH R; ROLSTON K; LUNA M; GOODRICH J; LEWIS V; MIRZA NQ; ANDREEFF M; KOLLER C; ELTING L; BODEY GP; WHIMBEY E
      INFLUENZA AMONG HOSPITALIZED ADULTS WITH LEUKEMIA

      Clinical infectious diseases
    61. NICHOLSON KG; KENT J; HAMMERSLEY V; CANCIO E
      ACUTE VIRAL-INFECTIONS OF UPPER RESPIRATORY-TRACT IN ELDERLY PEOPLE LIVING IN THE COMMUNITY - COMPARATIVE, PROSPECTIVE, POPULATION-BASED STUDY OF DISEASE BURDEN

      BMJ. British medical journal
    62. SUEN PC; TSAO KC; WU TL; NING HC; LIU TZ; SHIH SR
      REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION FOR AMANTADINE SUSCEPTIBILITY TESTING OF INFLUENZA-VIRUSES

      Biotechnology techniques
    63. PRUDHOMME IT; ZOUEVA O; WEBER JM
      AMANTADINE SUSCEPTIBILITY IN INFLUENZA-A VIRUS ISOLATES - DETERMINATION METHODS AND LACK OF RESISTANCE IN A CANADIAN SAMPLE, 1991-94

      Clinical and diagnostic virology
    64. MERCHANT GI; MOWER WR; TALAN DA
      UPDATE ON EMERGING INFECTIONS FROM THE CENTERS-FOR-DISEASE-CONTROL AND PREVENTION - INFLUENZA - ED CONSIDERATIONS FOR THE 1997-98 SEASON

      Annals of emergency medicine
    65. DRINKA PJ; GRAVENSTEIN S; KRAUSE P; SCHILLING M; MILLER BA; SHULT P
      OUTBREAKS OF INFLUENZA-A AND INFLUENZA-B IN A HIGHLY IMMUNIZED NURSING-HOME POPULATION

      Journal of family practice
    66. ZIMMERMAN RK; RUBEN FL; AHWESH ER
      INFLUENZA, INFLUENZA VACCINE, AND AMANTADINE RIMANTADINE/

      Journal of family practice
    67. JUDD AK; SANCHEZ A; BUCHER DJ; HUFFMAN JH; BAILEY K; SIDWELL RW
      IN-VIVO ANTIINFLUENZA VIRUS ACTIVITY OF A ZINC-FINGER PEPTIDE

      Antimicrobial agents and chemotherapy
    68. ELSTER C; LARSEN K; GAGNON J; RUIGROK RWH; BAUDIN F
      INFLUENZA-VIRUS M1 PROTEIN BINDS TO RNA THROUGH ITS NUCLEAR-LOCALIZATION SIGNAL

      Journal of General Virology
    69. SERKEDJIEVA J; IVANOVA E
      COMBINED PROTECTIVE EFFECT OF AN IMMUNOSTIMULATORY BACTERIAL PREPARATION AND RIMANTADINE IN EXPERIMENTAL INFLUENZA-A VIRUS-INFECTION

      Acta virologica

    70. NOVEL DERIVATIVES OF ALPHA-D-NEURAMINIC ACID FOR THE TREATMENT OF VIRAL-INFECTION

      Expert opinion on therapeutic patents
    71. MONTO AS
      THE CLINICAL EFFICACY OF INFLUENZA VACCINATION

      PharmacoEconomics
    72. CIANCI C; CHUNG TDY; MEANWELL N; PUTZ H; HAGEN M; COLONNO RJ; KRYSTAL M
      IDENTIFICATION OF N-HYDROXAMIC ACID AND N-HYDROXYIMIDE COMPOUNDS THATINHIBIT THE INFLUENZA-VIRUS POLYMERASE

      Antiviral chemistry & chemotherapy
    73. ADAL KA; FLOWERS RH; ANGLIM AM; HAYDEN FG; TITUS MG; COYNER BJ; FARR BM
      PREVENTION OF NOSOCOMIAL INFLUENZA

      Infection control and hospital epidemiology
    74. NICHOLSON KG
      USE OF ANTIVIRALS IN INFLUENZA IN THE ELDERLY - PROPHYLAXIS AND THERAPY

      Gerontology
    75. MADREN LK; SHIPMAN C; HAYDEN FG
      IN-VITRO INHIBITORY EFFECTS OF COMBINATIONS OF ANTIINFLUENZA AGENTS

      Antiviral chemistry & chemotherapy
    76. EVANS KD; KLINE MW
      PROLONGED INFLUENZA-A INFECTION RESPONSIVE TO RIMANTADINE THERAPY IN A HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILD

      The Pediatric infectious disease journal
    77. OXFORD JS
      QUO-VADIS ANTIVIRAL AGENTS FOR HERPES, INFLUENZA AND HIV

      Journal of Medical Microbiology
    78. KLIMOV AI; ROCHA E; HAYDEN FG; SHULT PA; ROUMILLAT LF; COX NJ
      PROLONGED SHEDDING OF AMANTADINE-RESISTANT INFLUENZA-A VIRUSES BY IMMUNODEFICIENT PATIENTS - DETECTION BY POLYMERASE CHAIN-REACTION - RESTRICTION ANALYSIS

      The Journal of infectious diseases
    79. WU JC; PEET GW; COUTTS SJ; ECKNER RJ; GRIFFIN JA; FARINA PR
      NON-SIALATE INHIBITOR OF INFLUENZA A WSN/33 NEURAMINIDASE/

      Biochemistry
    80. HOUCK P; HEMPHILL M; LACROIX S; HIRSH D; COX N
      AMANTADINE-RESISTANT INFLUENZA-A IN NURSING-HOMES - IDENTIFICATION OFA RESISTANT VIRUS PRIOR TO DRUG-USE

      Archives of internal medicine
    81. MONTO AS
      VIRAL RESPIRATORY-INFECTIONS IN THE COMMUNITY - EPIDEMIOLOGY, AGENTS,AND INTERVENTIONS

      The American journal of medicine
    82. GOMOLIN IH; LEIB HB; ARDEN NH; SHERMAN FT
      CONTROL OF INFLUENZA OUTBREAKS IN THE NURSING-HOME - GUIDELINES FOR DIAGNOSIS AND MANAGEMENT

      Journal of the American Geriatrics Society
    83. CIAMPOR F; CMARKO D; CMARKOVA J; ZAVODSKA E
      INFLUENZA-VIRUS M2 PROTEIN AND HEMAGGLUTININ CONFORMATION CHANGES DURING INTRACELLULAR-TRANSPORT

      Acta virologica
    84. NATSINA VK; DRINEVSKY VP; MILKINT KK
      REMANTADINE THERAPY IN CHILDREN WITH INFL UENZA

      VESTNIK ROSSIISKOI AKADEMII MEDITSINSKIKH NAUK
    85. NEUMANN M; MULLER S; GROSSE J; LERCHE D; REHSE K
      PLATELET-AGGREGATION INHIBITING AND ANTICOAGULANT EFFECTS OF OLIGOAMINES .23. INFLUENCE OF THE OLIGOAMINE RE-1492 ON THE DEFORMABILITY OF RED-BLOOD-CELLS

      Archiv der pharmazie
    86. IKEDA S; NEYTS J; VERMA S; WICKRAMASINGHE A; MOHAN P; DECLERCQ E
      IN-VITRO AND IN-VIVO INHIBITION OF ORTHOMYXOVIRUS AND PARAMYXOVIRUS INFECTIONS BY A NEW CLASS OF SULFONIC-ACID POLYMERS INTERACTING WITH VIRUS-CELL BINDING AND OR FUSION/

      Antimicrobial agents and chemotherapy
    87. MALOY ML; WHITAKERDOWLING P; YOUNGNER JS
      DOMINANCE OF COLD-ADAPTED INFLUENZA-A VIRUS OVER WILD-TYPE VIRUSES ISAT THE LEVEL OF RNA-SYNTHESIS

      Virology
    88. KEMLER I; WHITTAKER G; HELENIUS A
      NUCLEAR IMPORT OF MICROINJECTED INFLUENZA-VIRUS RIBONUCLEOPROTEINS

      Virology
    89. KISELEV OI; MISHIN VP; EROSHKIN VI; KOZELETSKAYA KN; USOVA EV; RUDENKO VI; CHUPAKHIN ON
      SECONDARY STRUCTURE OF THE M2 PROTEIN OF TYPE-A INFLUENZA-VIRUS AND ITS ROLE IN RIMANTADINE AND DEYTIFORINE RESISTANCE

      Molecular biology
    90. WHARTON SA; BELSHE RB; SKEHEL JJ; HAY AJ
      ROLE OF VIRION M2 PROTEIN IN INFLUENZA-VIRUS UNCOATING - SPECIFIC REDUCTION IN THE RATE OF MEMBRANE-FUSION BETWEEN VIRUS AND LIPOSOMES BY AMANTADINE

      Journal of General Virology
    91. MONTO AS
      USING ANTIVIRAL AGENTS TO CONTROL OUTBREAKS OF INFLUENZA-A INFECTION

      Geriatrics
    92. COLACINO JM; BIRCH GM; TANG JC
      CELLULAR-METABOLISM AND ANTIINFLUENZA ACTIVITY OF 1,3,4-THIADIAZOL-2-YLCYANAMIDE (LY217896)

      Antiviral chemistry & chemotherapy
    93. KISELEV OI; BLINOV VM; KOZELETSKAYA KN; ILYENKO VI; PLATONOV VG; CHUPAKHIN ON; STUKOVA MA; KARGINOV VA
      MOLECULAR MECHANISM OF ACTION OF ANTIVIRA L ADAMANTANE AGENTS

      VESTNIK ROSSIISKOI AKADEMII MEDITSINSKIKH NAUK
    94. WOODS JM; BETHELL RC; COATES JAV; HEALY N; HISCOX SA; PEARSON BA; RYAN DM; TICEHURST J; TILLING J; WALCOTT SM; PENN CR
      ANIDINO-2,4-DIDEOXY-2,3-DEHYDRO-N-ACETYLNEURAMINIC ACID IS A HIGHLY EFFECTIVE INHIBITOR BOTH OF THE SIALIDASE (NEURAMINIDASE) AND OF GROWTHOF A WIDE-RANGE OF INFLUENZA-A AND INFLUENZA-B VIRUSES IN-VITRO

      Antimicrobial agents and chemotherapy
    95. BRON R; KENDAL AP; KLENK HD; WILSCHUT J
      ROLE OF THE M2 PROTEIN IN INFLUENZA-VIRUS MEMBRANE-FUSION - EFFECTS OF AMANTADINE AND MONENSIN ON FUSION KINETICS

      Virology
    96. WANG C; TAKEUCHI K; PINTO LH; LAMB RA
      ION-CHANNEL ACTIVITY OF INFLUENZA-A VIRUS M(2) PROTEIN - CHARACTERIZATION OF THE AMANTADINE BLOCK

      Journal of virology
    97. BLACK RA; ROTA PA; GORODKOVA N; CRAMER A; KLENK HD; KENDAL AP
      PRODUCTION OF THE M2-PROTEIN OF INFLUENZA-A VIRUS IN INSECT CELLS IS ENHANCED IN THE PRESENCE OF AMANTADINE

      Journal of General Virology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/08/20 alle ore 00:54:43